Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-022975
Filing Date
2013-04-19
Accepted
2013-04-19 21:50:08
Documents
2
Period of Report
2012-12-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd377291.html 3  
1 FORM 3 rrd377291.xml 3 3139
2 POWER OF ATTORNEY rrd339098_383088.htm EX-24. 5332
  Complete submission text file 0001181431-13-022975.txt   10117
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 617-444-8424
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

EIN.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address
Martignetti Anthony (Reporting) CIK: 0001574697 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14895 | Film No.: 13772624